IP Library Patent Application 14876792
Patent Application
App. No. 14/876,792

Stable Silk Protein Fragment Compositions

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/876,792
Abstract

A composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals.

Claims (22)

1 - 20 . (canceled)

21 . A method of preparing a silk composition comprising the steps of:

(a) degumming a silk source by adding the silk source to a boiling (100° C.) aqueous solution of sodium carbonate for a treatment time of between about 30 minutes to about 60 minutes;

(b) removing sericin from the solution to produce a silk fibroin extract comprising non-detectable levels of sericin;

(c) draining the solution from the silk fibroin extract;

(d) dissolving the silk fibroin extract in a solution of lithium bromide having a starting temperature upon placement of the silk fibroin extract in the lithium bromide solution that ranges from about 80° C. to about 140° C.;

(e) maintaining the solution of silk fibroin-lithium bromide in a dry oven having a temperature in the range between about 60° C. to about 100° C. for a period of at least 1 hour;

(f) removing the lithium bromide from the silk fibroin extract; and

(g) producing an aqueous solution of silk protein fragments; wherein the aqueous solution of silk protein fragments does not spontaneously or gradually gelate and does not visibly change in color or turbidity when in a solution for at least 10 days.

22 . The product of the process of claim 21 , wherein the aqueous solution comprises pure silk fibroin-based protein fragments having an average weight average molecular weight ranging from about 39 kDa to about 80 kDa and a polydispersity of between about 1.5 and about 3.0.

23 . The product of claim 22 wherein the inorganic residuals include lithium bromide and wherein the organic residuals include sodium carbonate.

24 . The product of claim 22 wherein the lithium bromide residuals are measurable using a high-performance liquid chromatography lithium bromide assay, and the sodium carbonate residuals are measurable using a high-performance liquid chromatography sodium carbonate assay.

25 . The product of claim 22 in a sealed container.

26 . The method of claim 21 further comprising the step of adding one or more molecules selected from the group consisting of therapeutic agents, growth factors, antioxidants, proteins, vitamins, carbohydrates, polymers, nucleic acids, salts, acids, bases, biomolecules, glycosamino glycans, polysaccharides, extracellular matrix molecules, metals, metal ion, metal oxide, synthetic molecules, polyanhydrides, cells, fatty acids, fragrance, minerals, plants, plant extracts, preservatives and essential oils.

27 . The method of claim 21 further comprising the step of adding vitamin C or a derivative thereof.

28 . The method of claim 21 further comprising the step of adding an alpha hydroxy acid selected from the group consisting of glycolic acid, lactic acid, tartaric acid and citric acid.

29 . The method of claim 21 further comprising the step of adding hyaluronic acid or its salt form at a concentration of about 0.5% to about 10.0%.

30 . The method of claim 21 further comprising at least one of zinc oxide or titanium dioxide.

31 . The product of claim 22 wherein the pure silk fibroin-based protein fragments are hypoallergenic.

32 . The product of claim 22 having less than 10 colony forming units per gram.

33 . The product of claim 21 wherein the average weight average molecular weight range and the polydispersity are measurable using a high-performance liquid chromatography assay.

34 . The method of claim 21 , wherein the aqueous solution of silk protein fragments does not spontaneously or gradually gelate and does not visibly change in color or turbidity when in a solution for at least 30 days.

Assignments (5)
CHANGE OF NAME Recorded Feb 25, 2019
From: SILK, INC.
To: EVOLVED BY NATURE, INC.
Reel/Frame 048423/0276 →
CHANGE OF NAME Recorded Feb 21, 2019
From: SILK THERAPEUTICS, INC.
To: SILK, INC.
Reel/Frame 048407/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2019
From: ALTMAN, GREGORY H.
To: SILK THERAPEUTICS, INC.
Reel/Frame 048371/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2019
From: ALTMAN, GREGORY H.; HORAN, REBECCA L.; DOW, RACHEL LEE; HASS, DYLAN S.; LIND, RACHEL M.
To: SILK THERAPEUTICS, INC.
Reel/Frame 048372/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2019
From: ALTMAN, GREGORY H.; HORAN, REBECCA L.; DOW, RACHEL LEE; HASS, DYLAN S.; LIND, RACHEL M.
To: SILK THERAPEUTICS, INC.
Reel/Frame 048372/0232 →